0.1 ML Syfovre 150 MG/ML Injection
- RxCUI
- 2630853
- RxNorm name
- 0.1 ML Syfovre 150 MG/ML Injection
- Display name
- 0.1 ML Syfovre 150 MG/ML Injection
- Full name
- 0.1 ML Syfovre 150 MG/ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:17
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Syfovre | PEGCETACOPLAN | Apellis Pharmaceuticals, Inc. | b4434e61-9ec9-4e0e-bd60-45aaa0a87e64 | 2025-09-16 | Warnings, Adverse reactions | 2630853 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b4434e61-9ec9-4e0e-bd60-45aaa0a87e64 | SYFOVRE 15 MG in 0.1 ML Injection [PSN] · 0.1 ML pegcetacoplan 150 MG/ML Injection [Syfovre] [SBD] · 0.1 ML Syfovre 150 MG/ML Injection [SY] · Syfovre 15 MG per 0.1 ML Injection [SY] | 4 | 12 | These highlights do not include all the information needed to use SYFOVRE safely and effectively. See full prescribing information for SYFOVRE. SYFOVRE ® (pegcetacoplan injection), for intravitreal use Initial U.S. Approval: 2021 | 20250916 |